BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 20124165)

  • 1. Time trends and local variation in primary treatment of localized prostate cancer.
    Cooperberg MR; Broering JM; Carroll PR
    J Clin Oncol; 2010 Mar; 28(7):1117-23. PubMed ID: 20124165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.
    Cooperberg MR; Lubeck DP; Meng MV; Mehta SS; Carroll PR
    J Clin Oncol; 2004 Jun; 22(11):2141-9. PubMed ID: 15169800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database.
    Burt LM; Shrieve DC; Tward JD
    Adv Radiat Oncol; 2018; 3(2):170-180. PubMed ID: 29904742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.
    Cooperberg MR; Vickers AJ; Broering JM; Carroll PR
    Cancer; 2010 Nov; 116(22):5226-34. PubMed ID: 20690197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
    D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Blank K; Broderick GA; Tomaszewski JE; Renshaw AA; Kaplan I; Beard CJ; Wein A
    JAMA; 1998 Sep; 280(11):969-74. PubMed ID: 9749478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer statistics, 2016.
    Siegel RL; Miller KD; Jemal A
    CA Cancer J Clin; 2016; 66(1):7-30. PubMed ID: 26742998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active surveillance for prostate cancer: a systematic review of the literature.
    Dall'Era MA; Albertsen PC; Bangma C; Carroll PR; Carter HB; Cooperberg MR; Freedland SJ; Klotz LH; Parker C; Soloway MS
    Eur Urol; 2012 Dec; 62(6):976-83. PubMed ID: 22698574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.
    Taplin ME; Montgomery B; Logothetis CJ; Bubley GJ; Richie JP; Dalkin BL; Sanda MG; Davis JW; Loda M; True LD; Troncoso P; Ye H; Lis RT; Marck BT; Matsumoto AM; Balk SP; Mostaghel EA; Penning TM; Nelson PS; Xie W; Jiang Z; Haqq CM; Tamae D; Tran N; Peng W; Kheoh T; Molina A; Kantoff PW
    J Clin Oncol; 2014 Nov; 32(33):3705-15. PubMed ID: 25311217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic burden of prostate cancer.
    Roehrborn CG; Black LK
    BJU Int; 2011 Sep; 108(6):806-13. PubMed ID: 21884356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of age at diagnosis on prostate cancer treatment and survival.
    Bechis SK; Carroll PR; Cooperberg MR
    J Clin Oncol; 2011 Jan; 29(2):235-41. PubMed ID: 21135285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.
    Cooperberg MR; Carroll PR
    JAMA; 2015 Jul; 314(1):80-2. PubMed ID: 26151271
    [No Abstract]   [Full Text] [Related]  

  • 12. Racial differences in time from prostate cancer diagnosis to treatment initiation: a population-based study.
    Stokes WA; Hendrix LH; Royce TJ; Allen IM; Godley PA; Wang AZ; Chen RC
    Cancer; 2013 Jul; 119(13):2486-93. PubMed ID: 23716470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term functional outcomes after treatment for localized prostate cancer.
    Resnick MJ; Koyama T; Fan KH; Albertsen PC; Goodman M; Hamilton AS; Hoffman RM; Potosky AL; Stanford JL; Stroup AM; Van Horn RL; Penson DF
    N Engl J Med; 2013 Jan; 368(5):436-45. PubMed ID: 23363497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-cancer mortality at 11 years of follow-up.
    Schröder FH; Hugosson J; Roobol MJ; Tammela TL; Ciatto S; Nelen V; Kwiatkowski M; Lujan M; Lilja H; Zappa M; Denis LJ; Recker F; Páez A; Määttänen L; Bangma CH; Aus G; Carlsson S; Villers A; Rebillard X; van der Kwast T; Kujala PM; Blijenberg BG; Stenman UH; Huber A; Taari K; Hakama M; Moss SM; de Koning HJ; Auvinen A;
    N Engl J Med; 2012 Mar; 366(11):981-90. PubMed ID: 22417251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
    Eggener SE; Scardino PT; Walsh PC; Han M; Partin AW; Trock BJ; Feng Z; Wood DP; Eastham JA; Yossepowitch O; Rabah DM; Kattan MW; Yu C; Klein EA; Stephenson AJ
    J Urol; 2011 Mar; 185(3):869-75. PubMed ID: 21239008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.
    Heidenreich A; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Mottet N; Schmid HP; van der Kwast T; Wiegel T; Zattoni F;
    Eur Urol; 2011 Jan; 59(1):61-71. PubMed ID: 21056534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.
    Bolla M; Van Tienhoven G; Warde P; Dubois JB; Mirimanoff RO; Storme G; Bernier J; Kuten A; Sternberg C; Billiet I; Torecilla JL; Pfeffer R; Cutajar CL; Van der Kwast T; Collette L
    Lancet Oncol; 2010 Nov; 11(11):1066-73. PubMed ID: 20933466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.
    Hugosson J; Carlsson S; Aus G; Bergdahl S; Khatami A; Lodding P; Pihl CG; Stranne J; Holmberg E; Lilja H
    Lancet Oncol; 2010 Aug; 11(8):725-32. PubMed ID: 20598634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09.
    Zietman AL; Bae K; Slater JD; Shipley WU; Efstathiou JA; Coen JJ; Bush DA; Lunt M; Spiegel DY; Skowronski R; Jabola BR; Rossi CJ
    J Clin Oncol; 2010 Mar; 28(7):1106-11. PubMed ID: 20124169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical prostatectomy versus observation for localized prostate cancer.
    Wilt TJ; Brawer MK; Jones KM; Barry MJ; Aronson WJ; Fox S; Gingrich JR; Wei JT; Gilhooly P; Grob BM; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Sharifi R; Blank W; Pandya P; Andriole GL; Culkin D; Wheeler T;
    N Engl J Med; 2012 Jul; 367(3):203-13. PubMed ID: 22808955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.